No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Long-term pembrolizumab monotherapy maintains efficacy despite the occurrence of immune-related adverse events in patients with advanced melanoma

byTeddy Guo

January 21, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

All Specialties

Oral remibrutinib hits Phase 3 primary endpoint for inducible hives

March 5, 2026

AI Roundup

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

February 20, 2026

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Weekly Rewinds

2 Minute Medicine Rewind February 16, 2026

February 16, 2026

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

January 28, 2026

Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT

Increased close contact leads to spread of Andes virus in Argentina

#VisualAbstract Oral poly(ADP-ribose) polymerase inhibitors were associated with an increased risk of myelodysplastic syndrome and acute myeloid leukaemia over placebo treatment in patients with cancer

Quick Take: Factors associated with successful discontinuation of immune suppression after allogenic hematopoietic cell transplantation

Oral azacytidine maintenance therapy improved survival outcomes in patients with acute myeloid leukemia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports